Healthcare Services

Oligonucleotide Synthesis Industry Expansion Forecast Showing Market Size of $26.08 Billion by 2030 at 17.1% CAGR

April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Oligonucleotide Synthesis Market Evolve From 2026 To 2030?

The oligonucleotide synthesis market size has witnessed rapid growth over recent years. It is anticipated to increase from $11.92 billion in 2025 to $13.9 billion in 2026, driven by a compound annual growth rate (CAGR) of 16.6%. The expansion observed in the historical period can be attributed to elements such as the high cost of synthesis equipment, limited availability of custom oligos, dependency on manual synthesis processes, low awareness among researchers, and lengthy production timelines.

The oligonucleotide synthesis market is anticipated to show significant expansion in the coming years, projected to reach $26.08 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.1%. This projected growth is primarily driven by an increasing need for therapeutic and diagnostic applications, the rising adoption of automated synthesis platforms, continuous advancements in gene therapy research, growing investments in biotechnology research, and the global spread of oligo-based research and diagnostics. Major trends expected during this forecast period involve progress in gene editing and personalized medicine, the incorporation of cloud-based data management platforms, the utilization of AI for sequence optimization and design, increased automation in oligonucleotide synthesis processes, and IoT-enabled equipment for monitoring and tracking processes.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12176&type=smp

What Drivers Are Influencing The Oligonucleotide Synthesis Market?

An anticipated surge in chronic disease cases is set to boost the expansion of the oligonucleotide synthesis market in the foreseeable future. These conditions are defined as ailments lasting a minimum of one year, necessitating ongoing medical care, and potentially deteriorating over time. Oligonucleotides operate through diverse pathways to influence the gene expression responsible for chronic illnesses. Specifically, they are capable of targeting mRNA, pre-mRNA, or non-coding RNA to adjust splicing occurrences, prompt degradation, or hinder protein translation. As an illustration, the World Health Organization, an intergovernmental organization based in Switzerland, reported in February 2024 that by 2050, more than 35 million new cancer cases are anticipated. This projection signifies a 77% rise when contrasted with the estimated 20 million cases in 2022. Consequently, the escalating incidence of both chronic and rare diseases is a key impetus for the expansion of the oligonucleotide synthesis market.

Which Segment Areas Are Covered In The Oligonucleotide Synthesis Market Analysis?

The oligonucleotide synthesis market covered in this report is segmented –

1) By Type: Custom Oligos, Predesigned Oligos

2) By Solution Type: Oligonucleotides, Reagents, Equipment, Services, Purification, Modification

3) By Application: Therapeutic Applications, Research Applications, Diagnostic Applications

Subsegments:

1) By Custom Oligos: Long Oligonucleotides, Short Oligonucleotides, Modified Oligonucleotides

2) By Predesigned Oligos: Gene-Specific Oligos, Probe Oligos, Primers For PCR And RT-PCR

What Trends Are Projected To Affect The Oligonucleotide Synthesis Market?

Major companies operating in the oligonucleotide synthesis market are strategically focusing on creating innovative DNA products to improve sequence accuracy, simplify operational procedures, and support advanced research endeavors. For example, in July 2024, Ansa Biotechnologies, Inc., a US-based entity focused on complex DNA production, introduced Ansa Clonal DNA and Ansa DNA Fragments. Ansa Clonal DNA delivers clonal, perfectly sequenced DNA, reaching lengths of up to 600 base pairs, thereby eliminating the need for assembly and offering exceptional accuracy for complex synthetic biology initiatives. This product guarantees error-free, instantly usable DNA sequences, making it a dependable choice for investigators. Ansa DNA Fragments provides sequence-verified linear double-stranded DNA fragments, also up to 600 base pairs, tailored for various research applications. Utilizing its novel enzymatic synthesis approach, Ansa consistently produces intricate DNA constructs, including repetitive elements and secondary structures, with high precision.

Which Global Companies Are Actively Competing In The Oligonucleotide Synthesis Market?

Major companies operating in the oligonucleotide synthesis market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Nitto Denko Avecia Inc., Alnylam Pharmaceuticals Inc., Maravai Life Sciences, LGC Limited, Ionis Pharmaceuticals Inc., GenScript Inc., Ajinomoto Bio-Pharma Services, Sarepta Therapeutics Inc., Integrated DNA Technologies Inc., Twist Bioscience Corporation, Eurogentec SA, Kaneka Eurogentec S.A., Biocomma Limited, Bio-Synthesis Inc., TriLink BioTechnologies Incorporated, Generi Biotech s.r.o., ATDBio Ltd., BioAutomation Corporation, Biolegio B.V., Dharmacon Research Inc.

Read the full oligonucleotide synthesis market report here:

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Oligonucleotide Synthesis Market?

North America was the largest region in the oligonucleotide synthesis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Oligonucleotide Synthesis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12176&type=smp

Browse Through More Reports Similar to the Global Oligonucleotide Synthesis Market 2026, By The Business Research Company

Sterilization Services Global Market Report

https://www.thebusinessresearchcompany.com/report/sterilization-services-global-market-report

Terminal Sterilization Services Global Market Report

https://www.thebusinessresearchcompany.com/report/terminal-sterilization-services-global-market-report

Sterilization Equipment Global Market Report

https://www.thebusinessresearchcompany.com/report/sterilization-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795